Suchergebnisse - "Vogelhuber, Martin"

1

Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience

von: Schelker, Roland Christian

2018, in: BMC cancer

Wird geladen...
2

Dasatinib reduces myelofibrosis by modulating pSTAT5 and NF-κB

von: Schelker, Roland Christian

2019, in: Blood cells, molecules & diseases

Wird geladen...
3

Associations between dyadic coping and supportive care needs: findings from a study with hematologic cancer patients and their partners

von: Weißflog, Gregor

2016, in: Supportive care in cancer

Wird geladen...
4

Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia

von: Hart, Christina

2015, in: Cancer microenvironment

Wird geladen...
5

Chemotherapy for metastatic colon cancer: No effect on survival when the dose is reduced due to side effects

von: Munker, Stefan

2018, in: BMC cancer

Wird geladen...
6

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma : results of the randomized placebo-controlled GHSG HD15EPO trial

von: Engert, Andreas

April 5, 2010, in: Journal of clinical oncology

Wird geladen...
7

Positron emission tomography-guided treatment in early-stage favorable hodgkin lymphoma : final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group

von: Fuchs, Michael

September 10, 2019, in: Journal of clinical oncology

Wird geladen...
8

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial

von: Behringer, Karolin

2015, in: Effects of shape functions on flexural–torsional buckling of fixed circular arches

Wird geladen...
9

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17) : a multicentre, open-label, randomised, phase 3 trial

von: Borchmann, Peter

1 February 2021, in: The lancet. Oncology

Wird geladen...
10

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial

von: Borchmann, Peter

2021transfer abstract, in: My

Wird geladen...
11

Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma

von: Fuchs, Michael

16 October 2023, in: Leukemia

Wird geladen...
12

Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13) : an open-label, randomised, non-inferiority trial

von: Behringer, Karolin

2015, in: The lancet

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!